Evidence map›Paper›PMID 23871851›Full record

ArticleBone2013

In vivo reference point indentation reveals positive effects of raloxifene on mechanical properties following 6 months of treatment in skeletally mature beagle dogs.

Mohammad Aref, Maxime A Gallant, Jason M Organ, Joseph M Wallace, Christopher L Newman, David B Burr, Drew M Brown, Matthew R Allen

Open access · greenAbstract read
In one paragraph

Article in Bone, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
9.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. True Gold or Pyrite: A Review of Reference Point Indentation for Assessing Bone Mechanical Properties In Vivo.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Review
  10. Identifying Novel Clinical Surrogates to Assess Human Bone Fracture Toughness.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. In vivo assessment of bone quality in postmenopausal women with type 2 diabetes.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mohammad ArefDepartment of Anatomy and Cell Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Maxime A Gallant
Jason M Organ
Joseph M Wallace
Christopher L Newman
David B Burr
Drew M Brown
Matthew R Allen
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineUniversity of Indianapolis · US

Funding

Enhancing bone strength using combination drug therapyR01AR062002 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ALLEN, MATTHEW R · 2012 to 2016
$2.4M
NIAMS NIH HHS AR 62002NIAMS NIH HHS R01 AR062002
6 · The paper itself

Abstract

Raloxifene treatment has been shown previously to positively affect bone mechanical properties following 1 year of treatment in skeletally mature dogs. Reference point indentation (RPI) can be used for in vivo assessment of mechanical properties and has been shown to produce values that are highly correlated with properties derived from traditional mechanical testing. The goal of this study was to use RPI to determine if raloxifene-induced alterations in mechanical properties occurred after 6 months of treatment. Twelve skeletally mature female beagle dogs were treated for 6 months with oral doses of saline vehicle (VEH, 1 ml/kg/day) or a clinically relevant dose of raloxifene (RAL, 0.5 mg/kg/day). At 6 months, all animals underwent in vivo RPI (10N force, 10 cycles) of the anterior tibial midshaft. RPI data were analyzed using a custom MATLAB program, designed to provide cycle-by-cycle data from the RPI test and validated against the manufacturer-provided software. Indentation distance increase (IDI), a parameter that is inversely related to bone toughness, was significantly lower in RAL-treated animals compared to VEH (-16.5%), suggesting increased bone toughness. Energy absorption within the first cycle was significantly lower with RAL compared to VEH (-21%). These data build on previous work that has documented positive effects of raloxifene on material properties by showing that these changes exist after 6 months.

Indexed as

AnimalsBone Density Conservation AgentsBone RemodelingDisease Models, AnimalDogsFemaleOsteoporosisRaloxifene HydrochlorideBone Density Conservation AgentsRaloxifene HydrochlorideBone mechanicsBone remodelingIndentationOsteoporosis treatments

Identifiers

PMID23871851
PMCPMC3873633
OpenAlexW1993524228

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.